Effect of 1,4-cyclohexanediol on percutaneous absorption and penetration of azelaic acid

International Journal of Pharmaceutics

Volumn 387, Issue 1-2, 2010, Pages 167-171

  Li, Nan ^a   Su, Qian ^a   Tan, Fengping ^a   Zhang, Jerry ^a,b  

^a TIANJIN UNIVERSITY   (China)

^b Zymedis Pharmaceuticals Inc   (United States)

Author keywords

1,4 Cyclohexanediol; Azelaic acid; Penetration retardant; Percutaneous absorption

Indexed keywords

AZELAIC ACID; CYCLOHEXANE 1,4 DIOL; PENETRATION ENHANCING AGENT; UNCLASSIFIED DRUG;

ANIMAL TISSUE; ARTICLE; DRUG ABSORPTION; DRUG EFFICACY; DRUG FORMULATION; DRUG PENETRATION; DRUG RETENTION; DRUG SOLUBILITY; EPIDERMIS; HAIRLESS MOUSE; NONHUMAN; PRIORITY JOURNAL; RAT;

ADMINISTRATION, CUTANEOUS; ANIMALS; CYCLOHEXANOLS; DERMATOLOGIC AGENTS; DICARBOXYLIC ACIDS; MALE; PERMEABILITY; RATS; SKIN ABSORPTION;

EID: 77649186109     PISSN: 03785173     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijpharm.2009.12.025     Document Type: Article

References (20)

1. Abraham M.H., Chadha H.S., Mitchell R.C. The factors that influence skin penetration of solutes. J. Pharm. Pharmacol. 1995, 47:8-16.
2. Asbill C.S., Michniak B.B. Percutaneous penetration enhancers: local versus transdermal activity. Pharm. Sci. Technol. Today 2000, 3:36-41.
3. Bentley L.B., Marchetti J.H., Ricardo N., Ali-Abi Z., Collett J.H. Influence of lecithin on some physical chemical properties of poloxamer gels: rheological microscopic and in vitro permeation studies. Int. J. Pharm. 1999, 193:49-55.
4. Catz P., Friend D.R. Transdermal delivery of levonorgestrel. VIII. Effect of enhancers on rat skin, hairless mouse skin, hairless guinea pig skin, and human skin. Int. J. Pharm. 1990, 58:93-102.
5. Chattaraj S.C., Walker R.B. Penetration enhancer classification. Percutaneous Penetration Enhancers 1995, 5-20. CRC Press, Boca Raton, FL. E.W. Smith, H.I. Maibach (Eds.).
6. Cross S.E., Roberts M.S. The effect of occlusion on the epidermal penetration of parabens from a commercial test ointment, acetone and ethanol vehicles. J. Invest. Dermatol. 2000, 115:914-918.
7. Dermar M., Augusto M., Rudolf S., Constantin E. Effects of azelaic acid on proliferation and ultrastructure of mouse keratinocytes in vitro. J. Invest. Dermatol. 1989, 93:70-74.
8. Esther J., Aditya K.G., Melissa D., Mark G., Sally H. Systematic review of rosacea treatments. J. Am. Acad. Dermatol. 2007, 56:107-114.
9. Fang J.Y., Hwang T.L., Leu Y.L. Effect of enhancers and retarders on percutaneous absorption of flurbiprofen from hydrogels. Int. J. Pharm. 2003, 250:313-325.
10. Goodman M., Barry B.W. Action of penetration enhancers on human skin as assessed by the permeation of model drugs 5-fluorouracil and estradiol. I. Infinite dose technique. J. Invest. Dermatol. 1988, 91:323-327.
11. Hadgraft J., Peck J., Williams D.G., Pugh W.J., Allan G. Mechanisms of action of skin penetration enhancers/retarders: Azone and analogues. Int. J. Pharm. 1996, 141:17-25.
12. Ho H.O., Huang F.C., Sokoloski J.D., Sheu M.T. The influence of cosolvents on the in-vitro percutaneous penetration of diclofenac sodium from a gel system. J. Pharm. Pharmacol. 1994, 46:636-642.
13. Howes D., Guy R., Hadgraft J. Methods for assessing percutaneous absorption. The report and recommendations of ECVAM Workshop 13. Altern. Lab. Anim. 1996, 24:81-106.
14. Kim N., El-Khalili M., Henary M.M., Strekowski L., Michniak B.B. Percutaneous penetration enhancement activity of aromatic S,S-dimethyliminosulfuranes. Int. J. Pharm. 1999, 187:219-229.
15. Mansour A.M., Ibrahiern M.M. Simultaneous determination of azelaic and benzoic acids in topical preparations by liquid chromatography. J. Chromatogr. 2002, 55:435-437.
16. Potts R.O., Guy R.H. A predictive algorithm for skin permeability: the effects of molecular size and hydrogen bond activity. Pharm. Res. 1995, 12:1628-1633.
17. Rajadhyaksha V., Pfister W.R. Oxazolidinones. Drug Cosmet. Ind. 1996, 1. 36-47, 104-107.
18. Roberts M.S., Pugh W.J., Hadgraft J. Epidermal permeability-penetrant structure relationships: 2. The effect of H-bonding groups in penetrants on their diffusion through the stratum corneum. Int. J. Pharm. 1996, 132:23-32.
19. Seth B. Transdermal delivery using decyloxazolidin-2-one. Arzneim.-Forsch. Drug Res. 1999, 42:120-122.
20. Wertz P.W. Epidermal lipids. Seminars in Dermatology 1992, vol. 11:106-113.